A new survey by the National Community Pharmacists Association found that more than 90% of independent pharmacists may refuse to sell drugs targeted by Medicare Part D negotiations, potentially jeopardizing the Biden administration's efforts to lower prescription costs. 

A new study suggests that Medicare could save up to $366 million annually by introducing a new vial size for Alzheimer's drug lecanemab, which is currently only available in single-use, 500- and 200-milligram vials. 

The FDA has granted another exemption from certain requirements of the Drug Supply Chain Security Act to help eligible trading partners address challenges with data exchange while ensuring patient access to medications. 

GSK announced positive results from two phase 3 clinical trials evaluating its experimental drug, depemokimab, for chronic rhinosinusitis with nasal polyps affecting 4% of the population. 

Sanofi is entering negotiations with Clayton, Dublier & Rice regarding the potential sale of a 50% controlling stake in its consumer health business, Opella. 

Massachusetts pharmacist Glenn Chin was sentenced Oct. 11 in Michigan to 7 1/2 to 15 years in prison for his involvement in a 2012 meningitis outbreak that led to 11 deaths in Michigan and dozens more across the country, The Washington Post reported Oct. 11. 

The FDA has decided to reconsider its recent ban on the sale of compounded versions of tirzepatide, according to court documents obtained by Becker's. 

The landscape of community healthcare in the U.S. has been changing rapidly as major drugstore chains like Rite Aid, Walgreens and CVS announced widespread closures leading to widespread "pharmacy deserts," CNBC reported Oct. 11. 

The Biologics Price Competition and Innovation Act of (BPCI Act) of 2009 granted responsibility to the FDA for review and approval of a new class of pharmaceuticals referred to as "Biosimilars." (1)

Danco Laboratories is planning to seek FDA approval for the use of abortion pill Mifeprex for the treatment of miscarriages, The Wall Street Journal reported Oct. 8. 

GSK has reached  agreements with 10 plaintiff firms to settle around 80,000 state court product liability cases related to its heartburn medication, Zantac, for $2.2 billion. 

The FDA authorized the Healgen Rapid Check COVID-19/Flu A&B Antigen Test for over-the-counter use, the first combination test to receive approval outside of an emergency context, ABC News reported Oct. 8. 

The two FDA-approved drugs have demonstrated in clinical trials the capability to slow cognitive decline by several months, The Washington Post reported Oct. 8. 

CMS published a list of generic drugs to be included under its proposed Medicare $2 Drug List Model Oct. 9. 

The American Society of Health-System Pharmacists is urging federal health officials to declare a national public health emergency over the IV fluid shortage.

A coalition of healthcare organizations led by the American Hospital Association has filed an amicus brief defending Minnesota's law protecting the 340B drug discount program. 

CVS Health is set to lay off more than 630 employees as part of a $2 billion cost-cutting initiative aimed at improving financial performance, The Boston Globe reported Oct. 7. 

Ten individuals, including five pharmaceutical distributor executives and five sales representatives and brokers, have been charged by the Department of Justice in connection with the unlawful distribution of nearly 70 million opioid pills and over 30 million doses of commonly abused prescription drugs. 

Novo Nordisk plans to invest approximately $158 million into revamping its Montes Claros manufacturing facility in Minas Gerais, Brazil, Bloomberg reported Oct. 5. 

Kroger Co. has finalized the sale of its speciality pharmacy business to Elevance Health, according to an Oct. 4 news release.